Cerebrovascular, Cognitive and Cardiac Benefits of SGLT2 Inhibitors Therapy in Patients with Atrial Fibrillation and Type 2 Diabetes Mellitus: Results from a Global Federated Health Network Analysis

  1. Proietti, R.
  2. Rivera-Caravaca, J.M.
  3. López-Gálvez, R.
  4. Harrison, S.L.
  5. Marín, F.
  6. Underhill, P.
  7. Shantsila, E.
  8. McDowell, G.
  9. Vinciguerra, M.
  10. Davies, R.
  11. Giebel, C.
  12. Lane, D.A.
  13. Lip, G.Y.H.
Journal:
Journal of Clinical Medicine

ISSN: 2077-0383

Year of publication: 2023

Volume: 12

Issue: 8

Type: Article

DOI: 10.3390/JCM12082814 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals